Marsh & McLennan Companies, Inc. (MRSH)
| Market Cap | 92.29B -10.8% |
| Revenue (ttm) | 27.95B +8.3% |
| Net Income | 3.98B -3.6% |
| EPS | 8.17 -1.9% |
| Shares Out | 477.21M |
| PE Ratio | 23.67 |
| Forward PE | 17.61 |
| Dividend | $3.96 (2.05%) |
| Ex-Dividend Date | Jul 23, 2026 |
| Volume | 1,644,362 |
| Open | 193.81 |
| Previous Close | 194.67 |
| Day's Range | 193.28 - 195.47 |
| 52-Week Range | 156.60 - 211.28 |
| Beta | 0.58 |
| Analysts | Hold |
| Price Target | 206.48 (+6.76%) |
| Earnings Date | Oct 22, 2026 |
About MRSH
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking... [Read more]
Financial Performance
In 2025, MRSH's revenue was $26.98 billion, an increase of 10.32% compared to the previous year's $24.46 billion. Earnings were $4.16 billion, an increase of 2.46%.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for MRSH stock is "Hold." The 12-month stock price target is $206.48, which is an increase of 6.76% from the latest price.
News
Marsh McLennan price target raised to $203 from $189 at BMO Capital
BMO Capital raised the firm’s price target on Marsh McLennan (MRSH) to $203 from $189 and keeps a Market Perform rating on the shares after meeting with its management team.
Marsh McLennan price target raised to $200 from $180 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Marsh McLennan (MRSH) to $200 from $180 and keeps an Equal Weight rating on the shares. The firm updated models in the…
The AI productivity payoff is coming. Here are 20 stocks primed to capture the gains as adoption spreads.
So far investors have been focused on artificial-intelligence infrastructure plays rather than productivity beneficiaries, says Goldman Sachs.
Mercer and Compa Join Forces to Bring Compensation Insights Into Everyday Workflows
NEW YORK & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Mercer, a business of Marsh (NYSE: MRSH) and a global leader in helping clients realize their investment objectives, shape the future of work and enh...
Marsh McLennan Agency to acquire Accel Holdings, terms not disclosed
Marsh McLennan (MRSH) Agency announced that it has reached an agreement to acquire Accel Holdings, a diversified independent insurance and advisory firm headquartered in Waverly, Iowa. Terms of the ac...
Marsh McLennan Agency to Acquire Accel Holdings, Inc.
WHITE PLAINS--(BUSINESS WIRE)--Marsh McLennan Agency (MMA), a business of Marsh (NYSE:MRSH) and a leading provider of business insurance, employee health and benefits, retirement and wealth, and priva...
Marsh McLennan price target raised to $216 from $212 at UBS
UBS raised the firm’s price target on Marsh McLennan (MRSH) to $216 from $212 and keeps a Buy rating on the shares.
Marsh to leverage SS&C Blue Prism WorkHQ
SS&C Technologies (SSNC) announced that Marsh (MRSH) will leverage SS&C Blue Prism WorkHQ to scale agentic automation across its business. The adoption of the agentic orchestration platform builds on ...
Marsh McLennan price target raised to $201 from $197 at Mizuho
Mizuho analyst Yaron Kinar raised the firm’s price target on Marsh McLennan (MRSH) to $201 from $197 and keeps a Neutral rating on the shares. The firm cites improved margin…
Marsh McLennan price target raised to $182 from $178 at BofA
BofA raised the firm’s price target on Marsh McLennan (MRSH) to $182 from $178 and keeps an Underperform rating on the shares. The firm’s EPS forecasts rise with higher revenue…
Marsh McLennan price target raised to $188 from $186 at Wells Fargo
Wells Fargo raised the firm’s price target on Marsh McLennan (MRSH) to $188 from $186 and keeps an Equal Weight rating on the shares. The firm notes the stock was…
Marsh McLennan downgraded to Neutral from Buy at Citi
Citi downgraded Marsh McLennan (MRSH) to Neutral from Buy with an unchanged price target of $200. The firm cites valuation for the downgrade, seeing a balanced risk/reward at current share…
Marsh McLennan price target raised to $180 from $175 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Marsh McLennan (MRSH) to $180 from $175 and keeps an Equal Weight rating on the shares. The firm updated its model to…
Marsh & McLennan Companies Earnings Call Transcript: Q2 2026
Revenue grew 6% to $7.4B with 9% adjusted EPS growth, driven by strong new business and talent acquisition despite pricing headwinds. The Thrive program accelerated investments in brand, sales, and AI, while capital deployment guidance was raised to $5.5B for 2026.
Marsh & McLennan Companies Earnings release: Q2 2026
Marsh & McLennan Companies released its Q2 2026 earnings on July 21, 2026, summarizing the period's financial results.
Marsh & McLennan Companies Quarterly report: Q2 2026
Marsh & McLennan Companies has published its Q2 2026 quarterly earnings report on July 21, 2026.
Marsh & McLennan Companies Slides: Q2 2026
Marsh & McLennan Companies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 21, 2026.
Marsh Reports Second Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the second quar...
Marsh Survey Reveals That Insurers' Private Credit Appetite Continues to Grow, but Discipline Remains Paramount
NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today released the findings of its 2026 Global Insur...
Marsh McLennan price target lowered to $178 from $179 at BofA
BofA analyst Joshua Shanker lowered the firm’s price target on Marsh McLennan (MRSH) to $178 from $179 and keeps an Underperform rating on the shares. Q2 featured several notable catastrophe…
AI is Creating a New Competitive Divide Across Transport, Logistics and Defense, New Report From Oliver Wyman Forum Finds
NEW YORK--(BUSINESS WIRE)--Oliver Wyman Forum, the think tank of Oliver Wyman, a global leader in management consulting and a business of Marsh (NYSE: MRSH), today released The Industrial AI Divide: H...
Marsh McLennan price target raised to $212 from $206 at JPMorgan
JPMorgan analyst Pablo Singzon raised the firm’s price target on Marsh McLennan (MRSH) to $212 from $206 and keeps an Overweight rating on the shares. The firm adjusted targets in…
Marsh McLennan price target lowered to $234 from $236 at Evercore ISI
Evercore ISI lowered the firm’s price target on Marsh McLennan (MRSH) to $234 from $236 and keeps an Outperform rating on the shares. P&C insurance markets are showing increasing pressure…
Marsh McLennan price target raised to $218 from $210 at Cantor Fitzgerald
Cantor Fitzgerald analyst Ryan Tunis raised the firm’s price target on Marsh McLennan (MRSH) to $218 from $210 and keeps an Overweight rating on the shares. The firm updated its…
Marsh McLennan price target raised to $197 from $194 at Mizuho
Mizuho raised the firm’s price target on Marsh McLennan (MRSH) to $197 from $194 and keeps a Neutral rating on the shares.